Dew, I could look it up, but it's easier to ask the board, are there any competing CD137 monoclonals?
Productive day for GTC on the newswires:
Google News Alert for: gtcb
GTC Biotherapeutics And LFB Biotechnologies Enter Strategic ...
PipelineReview.com (press release) - Barcelona,Spain
FRAMINGHAM, MA, USA and PARIS, France | Oct 02, 2006 | GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) and LFB- Biotechnologies, a wholly owned subsidiary of ...
Market Report -- In Play (GTCB)
MSN Money - USA
GTC Biotherapeutics awarded $1.4 mln in continued SBIR funding for CD137 monoclonal antibody program Co announces that it was awarded an additional grant of ...
GTC Biotherapeutics Awarded $1.4 Million in Continued SBIR Funding ...
Genetic Engineering News (press release) - New Rochelle,NY,USA
GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it was awarded an additional grant of $1.4 million for its CD137 monoclonal antibody ...
GTC Biotherapeutics Awarded $1.4 Million in Continued SBIR Funding ...
Business Wire (press release) - San Francisco,CA,USA
FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it was awarded an additional grant of $1.4 million for ...
